title: Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures.
abstract: BACKGROUND
  Transporters, ion pumps, and ion channels are membrane proteins that regulate selective permeability and maintain ionic gradients across cell membranes. Mutations in CACNA1A encoding a neuronal calcium channel and ATP1A2 encoding an ion pump cause episodic ataxia, hemiplegic migraine, and seizures. Mutant gene products of both CACNA1A and ATP1A2 may affect neurotransmission of glutamate, the most abundant excitatory amino acid neurotransmitter.
  
  
  METHODS
  We examined our patient population with episodic ataxia and hemiplegic migraine but with no mutation in either CACNA1A or ATP1A2. We looked for mutations in SLC1A3, which encodes the glutamate transporter excitatory amino acid transporter (EAAT) 1 that is important in removing glutamate from the synaptic cleft.
  
  
  RESULTS
  A patient with episodic ataxia, seizures, migraine, and alternating hemiplegia has a heterozygous mutation in SLC1A3 that is not present in his asymptomatic parents and controls. Expression studies of the mutant EAAT1 showed decreased expression of the protein with a markedly reduced capacity for glutamate uptake. When coexpressed, the mutant EAAT1 decreased the activity of wild-type EAAT1 but not of two other transporters EAAT2 or EAAT3, suggesting that mutant EAAT1 specifically multimerizes with wild-type EAAT1 to exert its dominant negative effect.
  
  
  CONCLUSIONS
  Our data show that a heterozygous mutation in EAAT1 can lead to decreased glutamate uptake, which can contribute to neuronal hyperexcitability to cause seizures, hemiplegia, and episodic ataxia.
authors.affiliation: Department of Neurology, School of Medicine, University of California, Los Angeles, CA 90095, USA.
authors.forename: J C
authors.initials: JC
authors.lastname: Jen
authors.forename: J
authors.initials: J
authors.lastname: Wan
authors.forename: T P
authors.initials: TP
authors.lastname: Palos
authors.forename: B D
authors.initials: BD
authors.lastname: Howard
authors.forename: R W
authors.initials: RW
authors.lastname: Baloh
mesh_terms: D000818:Animals; D001259:Ataxia / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D001921:Brain / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D001923:Brain Chemistry / Q000235:genetics; D001929:Brain Edema / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D019556:COS Cells; D002648:Child; D002522:Chlorocebus aethiops; D004252:DNA Mutational Analysis; D027341:Excitatory Amino Acid Transporter 1 / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing; D018698:Glutamic Acid / Q000378:metabolism*; D006429:Hemiplegia / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D006579:Heterozygote; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009154:Mutation / Q000235:genetics; D010375:Pedigree; D012640:Seizures / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology
chemical_list: D027341:Excitatory Amino Acid Transporter 1; C493394:SLC1A3 protein, human; D018698:Glutamic Acid